SeraGene Therapeutics is a privately held biotechnology company based in Vancouver, Canada that specializes in the development of long-lasting RNA-based therapies for treating blood coagulation disorders (bleeding, thrombosis, and inflammation).
With extensive expertise in nanomedicine and clotting biology, we hope to one day realize a future where patients with coagulation disorders no longer live in fear of their next bleed or clot